Related references
Note: Only part of the references are listed.Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population
Rong Xia et al.
CANCER CELL INTERNATIONAL (2021)
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale et al.
NATURE MEDICINE (2021)
Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14ARF-Mediated Sustained p53 Activation
Maja T. Tomicic et al.
CANCERS (2021)
Immunotherapy in colorectal cancer: current achievements and future perspective
Ahui Fan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Quantitative evaluation of the intratumoral distribution of platinum in oxaliplatin-treated rectal cancer: In situ visualization of platinum via synchrotron radiation X-ray fluorescence spectrometry
Ryo Koba et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors
Anna M. Varghese et al.
CLINICAL CANCER RESEARCH (2020)
Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway
Ye Zhang et al.
AGING-US (2020)
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer
Qing Zhou et al.
GENOME MEDICINE (2020)
Circular RNA circPITX1 knockdown inhibits glycolysis to enhance radiosensitivity of glioma cells by miR-329-3p/NEK2 axis
Yongchang Guan et al.
CANCER CELL INTERNATIONAL (2020)
Cancer type-dependent correlations between TP53 mutations and antitumor immunity
Lin Li et al.
DNA REPAIR (2020)
Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients
He Cheng et al.
CANCER MEDICINE (2020)
Activating miRNA-mRNA network in gemcitabine-resistant pancreatic cancer cell associates with alteration of memory CD4(+) T cells
Jianyou Gu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
The oncogenic potential of a mutant TP53 gene explored in two spontaneous lung cancer mice models
Julian Ramelow et al.
BMC CANCER (2020)
Molecular epidemiology and diagnostics of KRAS mutations in human cancer
Jozsef Timar et al.
CANCER AND METASTASIS REVIEWS (2020)
Metabolic heterogeneity and adaptability in brain tumors
Christian E. Badr et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma
Dezhi Li et al.
CANCER MANAGEMENT AND RESEARCH (2020)
The Multifaceted Roles of MSCs in the Tumor Microenvironment: Interactions With Immune Cells and Exploitation for Therapy
Andrea Papait et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Research progress of PD-1/PD-L1 immunotherapy in gastrointestinal tumors
Jiangang Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer
Seung Hwan Moon et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer
Zhan-Hong Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full- dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial
Stine Braendegaard Whither et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
MIR155HG is a prognostic biomarker and associated with immune infiltration and immune checkpoint molecules expression in multiple cancers
Lirong Peng et al.
CANCER MEDICINE (2019)
Association of metabolic and genetic heterogeneity in head and neck squamous cell carcinoma with prognostic implications: integration of FDG PET and genomic analysis
Jinyeong Choi et al.
EJNMMI RESEARCH (2019)
Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530
Silvia L. Locatelli et al.
CLINICAL CANCER RESEARCH (2019)
Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer
Manik Amin et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
Hongping Zheng et al.
HEPATOLOGY (2018)
Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis
Hsi-Hsien Hsu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Relevance of copper transporter 1 and organic cation transporters 1-3 for oxaliplatin uptake and drug resistance in colorectal cancer cells
I. Buss et al.
METALLOMICS (2018)
The association between copy number aberration, DNA methylation and gene expression in tumor samples
Wei Sun et al.
NUCLEIC ACIDS RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Role of epigenetics in lung cancer heterogeneity and clinical implication
Nian Dong et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Landscape of Microsatellite Instability Across 39 Cancer Types
Russell Bonneville et al.
JCO PRECISION ONCOLOGY (2017)
Epithelial-mesenchymal transition plays a critical role in drug resistance of hepatocellular carcinoma cells to oxaliplatin
Jun Li Ma et al.
TUMOR BIOLOGY (2016)
Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules
Elda Grabocka et al.
CELL (2016)
Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model
Toshiki Iwai et al.
ONCOLOGY REPORTS (2016)
Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
Run-Ze Shang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Epigenetic Aging Signatures Are Coherently Modified in Cancer
Qiong Lin et al.
PLOS GENETICS (2015)
Tumor-Reactive CD8+ T Cells in Metastatic Gastrointestinal Cancer Refractory to Chemotherapy
Simon Turcotte et al.
CLINICAL CANCER RESEARCH (2014)
Modulating T regulatory cells in cancer: how close are we?
Ashish Banerjee et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
Understanding resistance to combination chemotherapy
Justin R. Pritchard et al.
DRUG RESISTANCE UPDATES (2012)
Expansion of cancer care and control in countries of low and middle income: a call to action
Paul Farmer et al.
LANCET (2010)
Many faces of Ras activation
Laszlo Buday et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2008)
Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes
B Altenberg et al.
GENOMICS (2004)
Share Paper
